Bay Street News, July, 2020

NEW YORK, July 31, 2020 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on […]

JERSEY CITY, N.J., July 31, 2020 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a designer, manufacturer and […]

SANTA CLARA, Calif., July 31, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. will hold a webcast to discuss its third […]

TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Further to the announcement made June 1, 2020, AGF Management Limited (TSX:AGF.B) confirms […]

SALT LAKE CITY, July 31, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]

New Drug Application (NDA) and Marketing Authorization Application (MAA) Submissions for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH) Planned for the […]

NEW HAMPTON, N.Y., July 31, 2020 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today record second quarter net earnings […]

MIDDLETOWN, R.I., July 31, 2020 (GLOBE NEWSWIRE) — KVH Industries, Inc. (Nasdaq: KVHI) reported financial results for the quarter ended […]

RHB-204 is a potential first-line oral treatment for pulmonary nontuberculous mycobacteria (NTM) infections, a rare disease with no FDA-approved first-line […]

GEORGE TOWN, Grand Cayman, July 31, 2020 (GLOBE NEWSWIRE) —Operational and Strategic Highlights:Q2 2020 revenue was 17.3 Million, up 21.1% […]